Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
    • Bolivia Extends Deadline For Corporate Income Tax Returns, Payments
    • Brazil Adds New VAT Rules To Simples Nacional Regulations
    • FinCEN Confirms End Of US Beneficial Ownership Reporting
    • Mauritania Requires VAT On Cross-Border Electronic Services
    • Philippines Expands VAT Exemption For Medications
    • Taiwanese Lawmakers Approve Inheritance Tax Law Changes
    • UAE Extends Corporate Tax Exemption For Small Businesses
    • UK Making Tax Digital For Income Tax Reporting Begins
  • Articles
    • Articles

    Global Daily Tax News, Philippines Expands VAT Exemption For Medications, (Aug 13, 2026)

    The Philippines' Bureau of Internal Revenue has announced a further expansion of the value-added tax exemption for medicines.

    More than 2,200 medicines now benefit from the value-added tax exemption, following the issuance of Revenue Memorandum Circul ...

    The Philippines' Bureau of Internal Revenue has announced a further expansion of the value-added tax exemption for medicines.

    More than 2,200 medicines now benefit from the value-added tax exemption, following the issuance of Revenue Memorandum Circular (RMC) No. 87-2026, which now features 2,277 medications.

    BIR said the significant expansion of the list supports the President's pledge, made during his fifth State of the Nation Address, to expand access to quality healthcare by reducing the cost of essential medicines.

    Of the VAT-exempt medicines, 708 are for cancer, 537 for hypertension, 331 for diabetes, 300 for mental illnesses, 172 for high cholesterol, 152 for kidney disease, and 77 for tuberculosis.

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use